D
Didier Blaise
Researcher at French Institute of Health and Medical Research
Publications - 223
Citations - 8956
Didier Blaise is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 49, co-authored 223 publications receiving 8268 citations. Previous affiliations of Didier Blaise include Centre national de la recherche scientifique & University of Helsinki.
Papers
More filters
Journal ArticleDOI
Targeting natural killer cells and natural killer T cells in cancer.
TL;DR: The rational use of these cells in cancer immunotherapies awaits a better understanding of their effector functions, migratory patterns and survival properties in humans.
Journal ArticleDOI
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
M. Mohty,Florent Malard,M. Abecassis,Erik Aerts,Ahmed Alaskar,M Aljurf,Mutlu Arat,Peter Bader,Frédéric Baron,Ali Bazarbachi,Didier Blaise,Fabio Ciceri,Selim Corbacioglu,J.-H. Dalle,Fiona L Dignan,Takahiro Fukuda,Anne Huynh,Tamás Masszi,Mauricette Michallet,Arnon Nagler,Mairead NiChonghaile,S. Okamoto,A Pagliuca,C Peters,Finn Bo Petersen,Paul G. Richardson,Tapani Ruutu,Bipin N. Savani,E. Wallhult,Ibrahim Yakoub-Agha,R. F. Duarte,Enric Carreras +31 more
TL;DR: A new definition for diagnosis, and a severity-grading system for SOS/VOD in adult patients, are proposed on behalf of the European Society for Blood and Marrow Transplantation.
Journal ArticleDOI
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.
Dominique Maraninchi,Didier Blaise,Bernard Rio,Véronique Leblond,F. Dreyfus,Eliane Gluckman,Denis Guyotat,Jose-Luis Pico,Mauricette Michallet,N. Ifrah,A. Bordigoni +10 more
TL;DR: Without better control of host immunity and of the residual leukaemia T-cell depletion of the marrow, BMT should not be pursued in standard-risk patients.
Journal ArticleDOI
Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)
M. Mohty,Florent Malard,M. Abecassis,Erik Aerts,As. Alaskar,M Aljurf,Mutlu Arat,Peter Bader,Frédéric Baron,Ali Bazarbachi,Didier Blaise,Fabio Ciceri,Selim Corbacioglu,J.-H. Dalle,R. F. Duarte,Takahiro Fukuda,Anne Huynh,Tamás Masszi,Mauricette Michallet,Arnon Nagler,Mairead NiChonghaile,T. Pagluica,C Peters,Fb. Petersen,P. G. Richardson,Tapani Ruutu,B.N. Savani,Elisabeth Wallhult,Ibrahim Yakoub-Agha,Enric Carreras +29 more
TL;DR: This review aims to highlight, on behalf of the European Society for Blood and Marrow Transplantation, the current knowledge on SOS/VOD pathophysiology, risk factors, diagnosis and treatments.
Journal ArticleDOI
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Gérard Socié,Reginald A. Clift,Didier Blaise,Agnès Devergie,Olle Ringden,Paul J. Martin,Mats Remberger,H. Joachim Deeg,Tapani Ruutu,Mauricette Michallet,Keith M. Sullivan,Sylvie Chevret +11 more
TL;DR: Bu-CY and CY-TBI provided similar probabilities of cure for patients with CML and in patients with AML, a nonsignificant 10% lower survival rate was observed after Bu-Y, and late complications occurred equally after both conditioning regimens.